Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AMLX
PGEN
Add up to 3 more stocks
AMLX
Amylyx Pharmaceuticals, Inc.
+0.94%
$28.04+0.26Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$3.12B
52W Range
$10.83 - $41.14
PGEN
Precigen, Inc.
-2.45%
$7.55-0.19Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.69B
52W Range
$2.99 - $8.98
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | 44.06 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.04 | 61.77 |
| P/S Ratio | N/A | 31.40 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 37.0% |
| Operating Margin | 0.0% | -1100.8% |
| Net Margin | 0.0% | -184.0% |
| ROE | -63.6% | -361.9% |
| ROA | -57.5% | -92.6% |
| ROIC | -66.6% | -28.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.12 | 4.58 |
| Quick Ratio | 12.12 | 3.89 |
| Debt/Equity | 0.02 | 2.26 |
| Interest Coverage | N/A | -27.57 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.